BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19540398)

  • 1. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioscopic differences in neointimal coverage and in persistence of thrombus between sirolimus-eluting stents and bare metal stents after a 6-month implantation.
    Takano M; Ohba T; Inami S; Seimiya K; Sakai S; Mizuno K
    Eur Heart J; 2006 Sep; 27(18):2189-95. PubMed ID: 16893918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography.
    Matsumoto D; Shite J; Shinke T; Otake H; Tanino Y; Ogasawara D; Sawada T; Paredes OL; Hirata K; Yokoyama M
    Eur Heart J; 2007 Apr; 28(8):961-7. PubMed ID: 17135281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J; Ueda Y; Ogasawara N; Okada K; Hirayama A; Kodama K
    Am Heart J; 2006 Dec; 152(6):1168-74. PubMed ID: 17161071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Tomai F; Reimers B; De Luca L; Galassi AR; Gaspardone A; Ghini AS; Ferrero V; Favero L; Gioffrè G; Prati F; Tamburino C; Ribichini F
    Diabetes Care; 2008 Jan; 31(1):15-9. PubMed ID: 17909090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
    Habara S; Mitsudo K; Goto T; Kadota K; Fujii S; Yamamoto H; Kato H; Takenaka S; Fuku Y; Hosogi S; Hirono A; Yamamoto K; Tanaka H; Hasegawa D; Nakamura Y; Tasaka H; Otsuru S; Okamoto Y; Yamada C; Miyamoto M; Inoue K
    Heart; 2008 Sep; 94(9):1162-5. PubMed ID: 18032460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation.
    Tanaka N; Terashima M; Kinoshita Y; Kimura M; Nasu K; Ehara M; Tsuchikane E; Matsubara T; Asakura Y; Katoh O; Suzuki T
    J Invasive Cardiol; 2008 Oct; 20(10):505-10. PubMed ID: 18829993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy.
    Takano M; Yamamoto M; Xie Y; Murakami D; Inami S; Okamatsu K; Seimiya K; Ohba T; Seino Y; Mizuno K
    Heart; 2007 Nov; 93(11):1353-6. PubMed ID: 17933992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plaque debulking before stent implantation on in-stent neointimal proliferation: a serial 3-dimensional intravascular ultrasound study.
    Takeda Y; Tsuchikane E; Kobayashi T; Terai K; Kobayashi Y; Nakagawa T; Sakurai M; Awata N; Kobayashi T
    Am Heart J; 2003 Jul; 146(1):175-82. PubMed ID: 12851628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).
    Hirohata A; Morino Y; Ako J; Sakurai R; Buchbinder M; Caputo RP; Karas SP; Mishkel GJ; Mooney MR; O'shaughnessy CD; Raizner AE; Wilensky RL; Williams DO; Wong SC; Yock PG; Honda Y; Moses JW; Fitzgerald PJ;
    Am J Cardiol; 2006 Dec; 98(11):1464-7. PubMed ID: 17126651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation.
    Chung WS; Park CS; Seung KB; Kim PJ; Lee JM; Koo BK; Jang YS; Yang JY; Yoon JH; Kim DI; Yoon YW; Park JS; Cho YH; Park SJ
    Int J Cardiol; 2008 Apr; 125(3):325-31. PubMed ID: 17434616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sirolimus-eluting stent on calcified coronary lesions.
    Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2008 Jan; 121(1):6-11. PubMed ID: 18208656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
    Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
    Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.